Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD.
Hepatol Int. 2023 Feb;17(1):190-201. doi: 10.1007/s12072-022-10420-w. Epub 2022 Sep 24.
Hepatol Int. 2023.
PMID: 36152131
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
Tang LJ, Sun DQ, Song SJ, Yip TC, Wong GL, Zhu PW, Chen SD, Karsdal M, Leeming DJ, Jiang P, Wang C, Chen Q, Byrne CD, Targher G, Eslam M, George J, Wong VW, Zheng MH.
Tang LJ, et al.
Liver Int. 2024 May;44(5):1129-1141. doi: 10.1111/liv.15878. Epub 2024 Mar 1.
Liver Int. 2024.
PMID: 38426611
Item in Clipboard
Cite
Cite